<div id="readability-page-1"><div><p><span>Kaye Edward M Director of Stoke Therapeutics Inc [STOK] filed a Form 4 on December 3, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:</span></p><div><table><tbody><tr><th><span>Date</span></th><th><span>Transaction</span></th><th><span>Shares</span></th><th><span>Price</span></th><th><span>Value</span></th></tr><tr><td><span>12/1/24</span></td><td><span>Exercise(1)</span></td><td><span>4,317</span></td><td><span>$0.00</span></td><td><span>N/A</span></td></tr><tr><td><span>12/2/25-12/3/25</span></td><td><span>Surrender(2)</span></td><td><span>2,136</span></td><td><span>$30.22</span></td><td><span>$64,541</span></td></tr></tbody></table></div><p><span>Ending Holdings: 51,305 - Direct</span></p><div><table><tbody><tr><td><span>(1)</span></td><td><span>Exercised 1 year before expiration date.</span></td></tr><tr><td><span>(2)</span></td><td><span>Surrender of shares back to company to pay option exercise cost and/or resulting tax liability.</span></td></tr></tbody></table></div><p><span>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.</span></p><p><span>Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.</span></p><span> </span></div></div>

STOK

<p>Kaye Edward M, Director of Stoke Therapeutics Inc, filed a Form 4 with the SEC on December 3, 2025, disclosing changes in ownership. He exercised 4,317 shares on 12/1/24 and surrendered 2,136 shares between 12/2/25 and 12/3/25 at $30.22 per share, valued at $64,541, to cover option exercise costs and tax liabilities. His ending holdings are 51,305 shares directly.</p>

Dir Kaye Acquires 2,181 Of Stoke Therapeutics Inc [STOK]